Funding & Awards

Telomere Shortening in Cancer and Aging

Miguel GODINHO FERREIRA, Research Director, DR2 CNRS

Core funding for the IRCAN is provided by the University Côte d'Azur, the CNRS and the INSERM



Research projects from the team are supported by:



2019-2022: Fondation pour la Recherche Médicale (Équipes FRM) - The gut as an aging initiator organ of zebrafish. EQU201903007804, France.

2019-2020: Université Côte d’Azur Installation Grant - Does aging confer a tumor-prone microenvironment? Action 2 de l'Académie 4.



2016-2019: Fondation ARC - Establishing anti-telomerase therapeutics for invasive melanoma in zebrafish. PJA 20161205137, France.

2016-2019: FCT - Age as a carcinogen: is telomere-shortening the culprit?. PTDC/BIM-ONC/3402/2014, Portugal.

2012-2017: Howard Hughes Medical Institute International Early Career Scientist, USA.


Research teams